Wednesday, January 23, 2008
One positive aspect from the ENHANCE study was that ezitimibe appears to be quite safe. There was no additional risk to liver or muscle when ezitimibe was given with a statin. At least ezetimibe is not physically hurting people, but financially it may be another story. A 1 month supply of Zetia or Vytorin costs ~$90 while a month's supply of generic simvastatin costs ~$30. I suppose we'll have to wait a little longer before we'll know if taking this medication is actually helping people other than the shareholders of Merck and Schering-Plough.
